Research from the UK Health Security Agency (UKHSA) has found the RSV vaccine is 72% effective in preventing hospitalisation ...

Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...

Pregnant women in England urged to get the RSV vaccine from 28 weeks to protect babies from respiratory syncytial virus, says NHS chief ...

The study found the program was more than 85% effective in reducing infant hospitalizations, emergency-room consultations and ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Children hospitalized with RSV showed higher risk for ICU admission, IMV, and supplemental oxygen than children hospitalized with COVID-19 or influenza.

Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

NHS England is rolling out the one-off injection medication, nirsevimab, from late September to provide protection against RSV for eligible high-risk and very preterm babies who are born too early to ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex. This is the first FDA-cleared assay utilizing Roche's innovative TAGS (Temperature ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age ...